Lista de obras - Helen Cox - Dominio Público Uruguay

A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.

artículo científico

Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives

artículo científico publicado en 2015

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India

artículo científico publicado en 2012

Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India

artículo científico publicado en 2011

Are we really that good at treating tuberculosis?

artículo científico publicado en 2009

Better treatment of XDR tuberculosis needed in South Africa.

artículo científico publicado en 2014

Catecholamine Metabolites in Internal Jugular Plasma: A Window into the Human Brain

Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors

artículo científico publicado en 2010

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa

artículo científico publicado en 2014

Compassionate and optimum use of new tuberculosis drugs

artículo científico publicado en 2015

Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa

artículo científico publicado en 2015

Decentralisation of multidrug-resistant-tuberculosis care and management

artículo científico publicado en 2013

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

artículo científico publicado en 2012

Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs

artículo científico publicado en 2012

Drug-resistant tuberculosis: time for visionary political leadership

artículo científico publicado en 2013

Effect of multidrug resistance on global tuberculosis control.

artículo científico publicado en 2003

Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis

artículo científico publicado en 2008

Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa

artículo científico publicado en 2010

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

artículo científico publicado en 2015

Extensively drug-resistant tuberculosis in South Africa

artículo científico publicado en 2010

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

artículo científico publicado en 2011

First molecular epidemiology study of Mycobacterium tuberculosis in Kiribati

artículo científico publicado en 2013

HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis

artículo científico publicado en 2020

Household screening and multidrug-resistant tuberculosis

artículo científico publicado en 2010

Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial

artículo científico publicado en 2014

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.

artículo científico publicado en 2015

In reply. QTc prolongation and delamanid: access and safety.

artículo científico publicado en 2015

Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key

artículo científico publicado en 2016

Injections for health-related reasons amongst injecting drug users in New Delhi and Imphal, India

article

Linezolid for multidrug-resistant tuberculosis

artículo científico publicado en 2013

Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients

artículo científico publicado en 2015

Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.

artículo científico

Linezolid in drug-resistant tuberculosis: haste makes waste

artículo científico publicado en 2015

Long term efficacy of DOTS regimens for tuberculosis: systematic review.

artículo científico publicado en 2008

MDR tuberculosis and non-compliance with therapy

artículo científico publicado en 2012

Mineralocorticoid induced hypertension and noradrenaline spillover in man.

artículo científico publicado en 1994

Monoaminergic neuronal activity in subcortical brain regions in essential hypertension

artículo científico publicado en 1994

Moxifloxacin for tuberculosis – Authors' reply

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

artículo científico publicado en 2012

Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures

artículo científico publicado en 2007

Outbreak of multidrug-resistant tuberculosis on Daru Island

artículo científico publicado en 2016

Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

artículo científico publicado en 2012

Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa

artículo científico publicado en 2015

Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent

artículo científico publicado en 2013

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study

artículo científico publicado en 2021

Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study

artículo científico publicado en 2013

QTc prolongation and treatment of multidrug-resistant tuberculosis.

artículo científico

Rational use of moxifloxacin for tuberculosis treatment

artículo científico publicado en 2011

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

artículo científico publicado en 2012

Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance

artículo científico publicado en 2007

Sanatoria for drug-resistant tuberculosis: an outdated response

artículo científico publicado en 2012

Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

artículo científico publicado en 2009

Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.

artículo científico

Sympathetic nervous activity and the thermic effect of food in humans

artículo científico publicado en 1998

The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia

artículo científico publicado en 2005

The benefits and risks of mathematical modelling in tuberculosis

artículo científico publicado en 2014

The need to accelerate access to new drugs for multidrug-resistant tuberculosis

artículo científico publicado en 2015

Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success

artículo científico publicado en 2015

To treat or not to treat? Implementation of DOTS in Central Asia

artículo científico publicado en 2003

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities

artículo científico publicado en 2012

Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results

artículo científico publicado en 2009

Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance

artículo científico publicado en 2006

Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients

artículo científico publicado en 2013

Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study

artículo científico publicado en 2022

Wind-driven roof turbines: a novel way to improve ventilation for TB infection control in health facilities

artículo científico publicado en 2012

XDR tuberculosis can be cured with aggressive treatment

artículo científico publicado en 2008

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.

artículo científico publicado en 2015

embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation

artículo científico publicado en 2010

Lista de obras de Helen Cox

A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.

Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India

Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India

Are we really that good at treating tuberculosis?

Better treatment of XDR tuberculosis needed in South Africa.

Catecholamine Metabolites in Internal Jugular Plasma: A Window into the Human Brain

Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa

Compassionate and optimum use of new tuberculosis drugs

Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa

Decentralisation of multidrug-resistant-tuberculosis care and management

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs

Drug-resistant tuberculosis: time for visionary political leadership

Effect of multidrug resistance on global tuberculosis control.

Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis

Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

Extensively drug-resistant tuberculosis in South Africa

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

First molecular epidemiology study of Mycobacterium tuberculosis in Kiribati

HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis

Household screening and multidrug-resistant tuberculosis

Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.

In reply. QTc prolongation and delamanid: access and safety.

Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key

Injections for health-related reasons amongst injecting drug users in New Delhi and Imphal, India

Linezolid for multidrug-resistant tuberculosis

Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients

Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.

Linezolid in drug-resistant tuberculosis: haste makes waste

Long term efficacy of DOTS regimens for tuberculosis: systematic review.

MDR tuberculosis and non-compliance with therapy

Mineralocorticoid induced hypertension and noradrenaline spillover in man.

Monoaminergic neuronal activity in subcortical brain regions in essential hypertension

Moxifloxacin for tuberculosis – Authors' reply

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures

Outbreak of multidrug-resistant tuberculosis on Daru Island

Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa

Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study

Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study

QTc prolongation and treatment of multidrug-resistant tuberculosis.

Rational use of moxifloxacin for tuberculosis treatment

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance

Sanatoria for drug-resistant tuberculosis: an outdated response

Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.

Sympathetic nervous activity and the thermic effect of food in humans

The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia

The benefits and risks of mathematical modelling in tuberculosis

The need to accelerate access to new drugs for multidrug-resistant tuberculosis

Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success

To treat or not to treat? Implementation of DOTS in Central Asia

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities

Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results

Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance

Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients

Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study

Wind-driven roof turbines: a novel way to improve ventilation for TB infection control in health facilities

XDR tuberculosis can be cured with aggressive treatment

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.

embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation